Skip to content
2000
Volume 16, Issue 1
  • ISSN: 2667-3878
  • E-ISSN: 2667-3886

Abstract

Pharmaceutical oral dosage forms are tremendously preferred by both consumers as well as pharmaceutical manufacturers owing to the plethora of benefits they offer. Lozenges (LZs) are one of the dosage forms that provide a palatable means of drug administration and have great importance with respect to their pharmaceutical applications. LZs offer additional benefits to pediatric and geriatric patients, along with people having problems associated with the gastro-intestinal tract. Dysphagia is a common problem faced by all age groups, which gives rise to the need for LZs. Moreover, the foremost merit presented by the medicated LZs includes its augmented retention time in the oral cavity that results in an enhanced bioavailability for buccal or upper gastro-intestinal disorders. Further, LZs can also be used to bypass the first-pass effect. The present review covers various aspects of LZs such as formulation, manufacturing techniques, evaluation parameters, marketed products, patents, and a compilation of research work that has been done on lozenges as a delivery system.

Loading

Article metrics loading...

/content/journals/raddf/10.2174/2667387816666211231103759
2022-03-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/raddf/10.2174/2667387816666211231103759
Loading

  • Article Type:
    Review Article
Keyword(s): dysphagia; Lozenges; palatable; patents; patient compliance; sore throat
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test